Abstract:OBJECTIVE To summarize clinical features and diagnosis of Chinese infantile patients with glycogen storage disease type II (GSD II). METHOD Six infant patients with GSD II diagnosed from January 2012 to June 2014 in the Department of Pediatrics, Peking University First Hospital were enrolled into this study. Clinical information of the 6 patients, including clinical manifestation, blood biochemistry, chest X-ray, echocardiogram, electrocardiogram, acid alpha-glucosidase (GAA) activity and GAA gene mutation analysis by direct sequencing of polymerase chain reaction (PCR) product were reviewed. RESULT Of the 6 patients, five were female and one was male, five of whom were classic infantile type while the other one was atypical. The age of onset ranged from birth to 3-month-old. All patients had varying degrees of generalized muscle weakness, hypotonia and development retardation or retrogression. Other common findings were feeding difficulties in two patients, tongue weakness in two patients, respiratory distress in four patients, macroglossia in one patient, and hepatomegaly in two patients. Left ventricular hypertrophy and cardiomegaly were obvious in all the six patients. All six patients were found to have a enlarged heart in physical examination, and three patients who underwent a chest X-ray examination had an enlarged heart shadow. Four patients who had an echocardiography were found to have myocardial hypertrophy. The electrocardiogram in three patients showed short PR intervals and high voltage. The creatine kinase (CK) levels were three to seven times elevated. The mildest elevated CK was 441 IU/L, and the highest CK level was 1 238 U/L. Assay of GAA enzyme activity in whole blood showed significantly reduced activity (1.3 nmol/ (spot·d) to 2 nmol/(spot·d)) in the patients tested. Gene sequencing in 4 patients showed 8 pathogenic mutations, including 6 missense mutations, one nonsense mutation and one frameshift mutation. The missense mutations were c.998C > A (p.Thr333Lys), c.1280T > C (p.Met427Thr), c.1760T > C (p.Leu587Pro), c.1924G > T (p.Val642Phe), c.2012T > A (p.Met671Lys) and c.2105G > A (p.Arg702His). The nonsense mutation was c2662G > T (p.Glu888X), and the frameshift mutation was c2812_2813delTG (p.Cys938fs). The 5 classic infantile patients died at the age of 7 to 22 months. The atypical infantile patient was 2 years and five months old according to our latest follow up. CONCLUSION Infantile GSD II had similar motor manifestations and cardiac involvements, blood biochemical test, imaging findings, enzyme assays, though there were slight differences. The probability of GSD II should be taken into consideration if an infant has both muscular disease and cardiac involvement.

Clinical and Biochemical Diagnostic and Therapeutic Survey of Seven Patients with Lipid Storage Myopathy Due to Glutaric Aciduria Type II

Clinical, Pathological and Molecular Genetic Analysis of Pediatric Lipid Storage Myopathy

[Clinical and Laboratory Studies on 28 Patients with Glutaric Aciduria Type 1].

Clinical and Pathological Features of Late-onset Glycogen Storage Disease Type Ⅱ

Leucodystrophy induced by late onset 3-hydroxy-3-methylglutaric aciduria

Clinical and Mutational Spectra of 23 Chinese Patients with Glutaric Aciduria Type 1.

Navigating the Diagnostic Journey in Pediatric Gastroenterology: Decoding Recurrent Vomiting and Epigastric Pain in a Child with Glutaric Aciduria Type II

[Analysis of Clinical Features of 6 Patients with Infantile Type Glycogen Storage Disease Type II].

Clinical and genetic features of patients with glycogen storage disease type Ⅸa:An analysis of 20 cases

Cinical treatment of 3-hydroxy-3-methylglutaric aciduria and a novel mutation on 3-hydroxy-3-methylglutaryl-coenzyme A lyase gene

[Clinical characteristics and GAA gene mutation in children with glycogen storage disease type II: an analysis of 3 cases].

A clinical,electrophysiological and pathological study in 2 cases of late-onset systemic carnitine deficiency

[Expert Consensus for the Diagnosis and Treatment of Glutaricacidemia Type 1].

[Consensus on Screening, Diagnosis and Treatment of Multiple Acyl-Coa Dehydrogenase Deficiency].

Clinical features and genetic analysis of 5 cases of infantile-type glycogen storage disease type II: Case reports

Genetic analysis and long-term treatment monitoring of 11 children with glycogen storage disease type IIIa

Clinical Features and Electron Transfer Flavoprotein Dehydrogenase Gene Mutation Analysis in 35 Chinese Patients with Lipid Storage Myopathy

Diagnostic Challenges in Late Onset Multiple Acyl-CoA Dehydrogenase Deficiency: Clinical, Morphological, and Genetic Aspects

[Analysis of clinical features and genetic variants in three children with late-onset Multiple acyl-Coenzyme A dehydrogenase deficiency]

Clinical and genetic features of three patients with non-classical isovaleric aciduria

[Clinical Features and Acid Alpha-Glucosidase Gene Mutation in 7 Chinese Patients with Glycogen Storage Disease Type II].